Forget the Correction: This Stock Is Defying the Sell-Off, and There Might Be More Upside Ahead
The tech-heavy Nasdaq Composite index recently entered correction territory. Though it was able to climb out of it, equities ...
£10,000 invested in AstraZeneca shares 1 year ago is now worth…
AstraZeneca shares have recovered from their brief slump with investors broadly buoyed by the company’s long-term business ...
AstraZeneca snaps up Belgian cancer treatment business EsoBiotec in £770m deal
Astra will buy EsoBiotec for up to £770m comprised of an initial £327m payment and another £443m in the future if it hits ...
AstraZeneca Pharma shares gain 3% on CDSCO nod for expanded use of cancer drug Imfinzi
This approval allows the use of Durvalumab in combination with Tremelimumab, broadening treatment options for patients battling advanced-stage liver cancer.
M&A News: AstraZeneca Seals Belgian Firm EsoBiotec Deal to Boost Cell Therapy
Healthcare giant AstraZeneca (AZN) is set to buy Belgian firm EsoBiotec for up to $1 billion. The deal aims to speed up progress in cell ...
The Pharma Letter5d
AstraZeneca advances cell therapy ambition with acquisition of EsoBiotec
AstraZeneca (LSE: AZN) today revealed it has entered into a definitive agreement to acquire EsoBiotec, a Belgium-based ...
AstraZeneca to buy EsoBiotec for up to $1 billion
AstraZeneca is set to acquire biotechnology firm EsoBiotec for up to $1 billion, including a $425 million upfront payment and ...
Mint9d
Astrazeneca Pharma India share price
The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.